Agios Pharmaceuticals (AGIO) Other Working Capital Changes (2012 - 2026)

Agios Pharmaceuticals (AGIO) has 8 years of Other Working Capital Changes data on file, last reported at -$4.6 million in Q2 2026.

• Quarterly Other Working Capital Changes fell 9.43% year-over-year to -$4.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$17.6 million (down 10.9% YoY) and the FY2025 annual result came in at -$16.8 million, down 11.81% from the prior year.
• Other Working Capital Changes eased to -$4.6 million in Q2 2026, from -$4.5 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $5.3 million in Q3 2024 to a low of -$7.5 million in Q4 2022.
• A 5-year average of $703888.9 and a median of $1.3 million in 2024 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 266.22% in 2022, down 278.51% in 2022.
• Tracing AGIO's Other Working Capital Changes over 5 years: stood at -$3.2 million in 2022, then declined by 10.06% to -$3.5 million in 2023, then declined by 9.82% to -$3.8 million in 2024, then decreased by 12.01% to -$4.3 million in 2025, then declined by 6.17% to -$4.6 million in 2026.
• The last three Other Working Capital Changes figures came in at -$4.6 million (Q2 2026), -$4.5 million (Q1 2026), and -$4.3 million (Q4 2025), per Business Quant data.